The peritoneal dialysis (pd) patient contacted fresenius and reported having a drain complication during pd treatment with the liberty select cycler.The patient's pd nurse was aware of the issue and stated the patient had a large clot (fibrin sheath) removed from the pd catheter (not a fresenius product) approximately 2 weeks prior.The nurse confirmed the patient has had build-up of fibrin in the pd catheter and that the patient was using heparin, per standing orders, to mitigate fibrin formation.The nurse confirmed the patient did not have any adverse effects from use of any fresenius device, or product and completes treatment.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|